Ringlet, S., & Engel, D. (2022). Identification of the endogenous co-agonist of NMDA receptor in dopamine neurons from the substantia nigra [Paper presentation]. Belgian Society of Physiology and Pharmacology, Brussels, Belgium. |
Jehasse, K., & Ringlet, S. (2022). Mechanisms controlling the excitability of midbrain dopaminergic neurons [Paper presentation]. Dopamine meeting 2022. |
Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Vitello, M., Chua, H. C., Pless, S., Engel, D., Liégeois, J.-F., Lakaye, B., Roeper, J., & Seutin, V. (01 October 2021). The gating pore blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain dopaminergic neurons. Neuropharmacology, 197, 1-15. doi:10.1016/j.neuropharm.2021.108722 |
Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Lakaye, B., Liégeois, J.-F., Roeper, J., & Seutin, V. (22 May 2020). On the path to understanding pacemaking of dopaminergic neurons [Poster presentation]. Virtual Dopamine Meeting. |